Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

NCT07500259 is registered in ClinicalTrials.gov with Luxembourg Institute of Health as lead sponsor.

NCT NCT07500259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07500259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC
Lead sponsor
Luxembourg Institute of Health
Phase
Observational
Overall status
Recruiting
Start date
September 11, 2026
Completion date
November 1, 2034
Enrollment
188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, pdac - pancreatic ductal adenocarcinoma